Det kan være hensiktsmessig med ensartede besvarelser fra patologiavdelinger i hele landet. Dette vil kunne bidra til å få med alle faktorer som er viktige for stadieinndeling og for videre behandling. Se forslag til mal ved besvarelse av reseksjonspreparater med tykk- og endetarmskreft i vedlegg til dette kapittelet.
18. Patologi
18. 1. Makrohåndtering
18. 2. Mikrohåndtering
18. 3. UICC: TNM-klassifisering og stadieinndeling
18. 4. Histologisk gradering
18. 5. Lymfeknuter
18. 6. Histopatologisk evaluering av tumorrespons
18. 7. Polypper med adenocarcinom i tykk og endetarm
18. 8. Mal for tykktarmskreft
18. 9. Mal for endetarmskreft
18. 10. Tester for Lynch syndrome
18. 11. Molekylærpatologisk undersøkelse
18. 12. Spesifikt om immunhistokjemi (IHK)
18. 13. Spesifikt om deteksjon av mikrosatelittinstabilitet (MSI)
18. 14. Spesifikt om molekylære analyser
18. 15. Prøvetakning og besvarelse av molekylære analyser
Abrha, A., Shukla, N. D., Hodan, R., Longacre, T., Raghavan, S., Pritchard, C. C., Fisher, G., Ford, J., & Haraldsdottir, S. (2020). Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford. JNCI cancer spectrum, 4(5), pkaa054.
Al Sahaf, O., Myers, E., Jawad, M., Browne, T. J., Winter, D. C., & Redmond, H. P. (2011). The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer. Diseases of the Colon and Rectum, 54(8), 982-8.
Beaton, C., Twine, C. P., Williams, G. L., & Radcliffe, A. G. (2013). Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Disease, 15(7), 788-97.
Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjaerg, P. S., Hanberg-Sorensen, F., Bone, J., Jacobsen, N. O., Sell, A., ... et al. (1992). Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. British Journal of Cancer, 65(1), 102-7.
Betge, J., Pollheimer, M. J., Lindtner, R. A., Kornprat, P., Schlemmer, A., Rehak, P., Vieth, M., Hoefler, G., & Langner, C. (2012). Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer, 118(3), 628-38.
Bosch, S. L., Teerenstra, S., de Wilt, J. H., Cunningham, C., & Nagtegaal, I. D. (2013). Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy, 45(10), 827-34.
Burgart, L. J., Shi, C., Berho, M. E., Driman, D. K., Fitzgibbons, P., Frankel, W. L., ... Hill, K. A. (2020). Protocol for the Examination of Excisional Biopsy Specimens From Patients With Primary Carcinoma of the Colon and Rectum (Version 4.1.0.0). Northfield, Illinois: College of American Pathologists. Hentet fra https://documents.cap.org/protocols/cp-gilower-colonrectum-biopsy-20-4100.pdf
Caputo, D., Caricato, M., La Vaccara, V., Taffon, C., Capolupo, G. T., & Coppola, R. (2014). T1 colorectal cancer: poor histological grading is predictive of lymph-node metastases. International Journal of Surgery (London, England), 12(3), 209-12.
Cercek, A., Lumish, M., Sinopoli, J., Weiss, J., Shia, J., Lamendola-Essel, M., El Dika, I. H., Segal, N., ... Diaz, L. A. ,. J. (2022). PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. New England Journal of Medicine, 386(25), 2363-2376.
Cervantes, A., Adam, R., Roselló, S., Arnold, D., Normanno, N., Taïeb, J., Seligmann, J., De Baere, T., ... Martinelli, E. (2023). Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 34(1), 10-32.
Chalabi, M., Fanchi, L. F., Dijkstra, K. K., Van den Berg, J. G., Aalbers, A. G., Sikorska, K., Lopez-Yurda, M., Grootscholten, C., ... Haanen, J. B. (2020). Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nature Medicine, 26(4), 566-576.
Chalabi, M., Verschoor, Y. L., van den Berg, J., Sikorska, K., Beets, G., Lent, A. V., Grootscholten, M. C., Aalbers, A., ... Haanen, J. B. A. G. (2022). LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study. Annals of Oncology, 33(Suppl 7), S1389.
Den norske legeforening (2012). Veileder i biopsibesvarelse av maligne svulster (2 utg.) Oslo:
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., ... Pages, F. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313(5795), 1960-1964.
Haddad, T. S., Lugli, A., Aherne, S., Barresi, V., Terris, B., Bokhorst, J. M., Brockmoeller, S. F., Cuatrecasas, M., ... Nagtegaal, I. D. (2021). Improving tumor budding reporting in colorectal cancer: a Delphi consensus study. Virchows Archiv, 479(3), 459-469.
Haggitt, R. C., Glotzbach, R. E., Soffer, E. E., & Wruble, L. D. (1985). Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology, 89(2), 328-36.
Haugland, H. K., Casati, B., Dorum, L. M., & Bjugn, R. (2011). Template reporting matters--a nationwide study on histopathology reporting on colorectal carcinoma resections. Human Pathology, 42(1), 36-40.
Japanese Society for Cancer of the Colon and Rectum (2019). Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. Journal of the anus, rectum and colon, 3(4), 175-195.
Koren, R., Siegal, A., Klein, B., Halpern, M., Kyzer, S., Veltman, V., & Gal, R. (1997). Lymph node-revealing solution: simple new method for detecting minute lymph nodes in colon carcinoma. Diseases of the Colon and Rectum, 40(4), 407-10.
Kouyama, Y., Kudo, S. E., Miyachi, H., Ichimasa, K., Hisayuki, T., Oikawa, H., Matsudaira, S., Kimura, Y. J., ... Hamatani, S. (2016). Practical problems of measuring depth of submucosal invasion in T1 colorectal carcinomas. International Journal of Colorectal Disease, 31(1), 137-46.
Kreftregisteret (27. april 2023). Tarmscreeningprogrammets kvalitetsmanual. [nettdokument]. Oslo: Kreftregisteret. Hentet 1. november 2023 fra https://www.kreftregisteret.no/screening/tarmscreening/for-helsepersonell/kvalitetsmanual/
Leijssen, L. G. J., Dinaux, A. M., Amri, R., Taylor, M. S., Deshpande, V., Bordeianou, L. G., Kunitake, H., & Berger, D. L. (2019). Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. Journal of Surgical Oncology, 119(6), 749-757.
Liebig, C., Ayala, G., Wilks, J., Verstovsek, G., Liu, H., Agarwal, N., Berger, D. H., & Albo, D. (2009). Perineural invasion is an independent predictor of outcome in colorectal cancer. Journal of Clinical Oncology, 27(31), 5131-7.
Loughrey, M. B., Arends, M., Brown, I., Burgart, L. J., Cunningham, C., Flejou, J. F., ... Kakar, S. (2020). Colorectal Cancer Histopathology Reporting Guide (1 utg.) Sydney: International Collaboration on Cancer Reporting. Hentet fra https://www.iccr-cancer.org/wp-content/uploads/2023/08/ICCR-Colorectal-1st-edn-v1.0-bookmark.pdf
Loughrey, M. B., Kent, O., Moore, M., Coghlin, C., Kelly, P., McVeigh, G., & Coleman, H. G. (2020). Impact on colorectal cancer pathology reporting practice of migration from TNM 5 to TNM 8. Histopathology, 77(2), 210-222.
Loughrey, M. B., Quirke, P., Shepherd, N. A. (2018). Standards and datasets for reporting cancers: dataset for histopathological reporting of colorectal cancer London: The Royal College of Pathologists. Hentet fra https://www.rcpath.org/static/c8b61ba0-ae3f-43f1-85ffd3ab9f17cfe6/G049-Dataset-for-histopathological-reporting-of-colorectal-cancer.pdf
Lugli, A., Kirsch, R., Ajioka, Y., Bosman, F., Cathomas, G., Dawson, H., El Zimaity, H., Flejou, J. F., ... Quirke, P. (2017). Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern Pathology, 30(9), 1299-1311.
Nagtegaal, I. D., & van Krieken, J. H. (2002). The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview. European Journal of Cancer, 38(7), 964-72.
Nakadoi, K., Tanaka, S., Kanao, H., Terasaki, M., Takata, S., Oka, S., Yoshida, S., Arihiro, K., & Chayama, K. (2012). Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. Journal of Gastroenterology and Hepatology, 27(6), 1057-62.
Newell, K. J., Sawka, B. W., Rudrick, B. F., & Driman, D. K. (2001). GEWF solution. Archives of Pathology and Laboratory Medicine, 125(5), 642-5.
Norderval, S., Solstad Ø, B., Hermansen, M., & Steigen, S. E. (2016). Increased lymph node retrieval decreases adjuvant chemotherapy rate for stage II colon cancer. Scandinavian Journal of Gastroenterology, 51(8), 949-55.
Pages, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., ... Galon, J. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. New England Journal of Medicine, 353(25), 2654-66.
Papke, D. J. ,. J., Yurgelun, M. B., Noffsinger, A. E., Turner, K. O., Genta, R. M., & Redston, M. (2022). Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas. New England Journal of Medicine, 387(18), 1714-1716.
Rosty, C., Brown, I., Cooper, H., Dekker, E., Driman, D. K., Gonzalez, R. S., ... Hewett, D. G. (2020). Colorectal Excisional Biopsy (Polypectomy) Histopathology Reporting Guide Sydney: International Collaboration on Cancer Reporting. Hentet fra https://www.iccr-cancer.org/datasets/published-datasets/digestive-tract/colorectal-polypectomy/
Ryan, R., Gibbons, D., Hyland, J. M., Treanor, D., White, A., Mulcahy, H. E., O'Donoghue, D. P., Moriarty, M., ... Sheahan, K. (2005). Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology, 47(2), 141-6.
Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., Kopetz, S. E., Lieu, C., ... Nowak, J. A. (2017). Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. Journal of Oncology Practice, 13(5), 333-337.
Sinicrope, F. A., & Sargent, D. J. (2012). Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clinical Cancer Research, 18(6), 1506-12.
Smith, K. D., Tan, D., Das, P., Chang, G. J., Kattepogu, K., Feig, B. W., Skibber, J. M., & Rodriguez-Bigas, M. A. (2010). Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Annals of Surgery, 251(2), 261-4.
Sobin, L. H., Gospodarowicz, M., Wittekind, C. (2016). TNM: classification of malignant tumors. Wiley-Blackwell.
Suzuki, H., Fujii, T., Asao, T., Tsutsumi, S., Wada, S., Araki, K., Kubo, N., Watanabe, A., ... Kuwano, H. (2014). Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases. World Journal of Surgery, 38(8), 2079-88.
Tasi, C. K., Chen, C. Y., Liu, C. Y., & Wu, Y. Y. (2012). Reliability and effectiveness of GEWF solution in the identification of lymph nodes in specimens of colorectal carcinoma. International Journal of Surgical Pathology, 20(6), 589-95.
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Ruschoff, J., Fishel, R., Lindor, N. M., ... Srivastava, S. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute, 96(4), 261-8.
Valtorta, E., Martino, C., Sartore-Bianchi, A., Penaullt-Llorca, F., Viale, G., Risio, M., Rugge, M., Grigioni, W., ... Gambacorta, M. (2015). Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Modern Pathology, 28(11), 1481-91.
Van Cutsem, E., Cervantes, A., Nordlinger, B., & Arnold, D. (2014). Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 25 Suppl 3, iii1-9. Erratum i: Ann Oncol 2015;26(Suppl 5):v174-7.
WHO Classification of Tumorous Editorial Board (2019). Digestive System Tumours. International Agency for Reasearch on Cancer.
Wijesuriya, R. E., Deen, K. I., Hewavisenthi, J., Balawardana, J., & Perera, M. (2005). Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly. Surgery Today, 35(6), 442-5.
Zwager, L. W., Bastiaansen, B. A. J., Montazeri, N. S. M., Hompes, R., Barresi, V., Ichimasa, K., Kawachi, H., Machado, I., ... Dekker, E. (2022). Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis. Gastroenterology, 163(1), 174-189.
Siste faglige endring: 20. desember 2023